Loading...
Femasys Inc.
FEMY•NASDAQ
Healthcare
Medical - Instruments & Supplies
$0.90
$-0.02(-1.66%)
Femasys Inc. (FEMY) Financial Performance & Income Statement Overview
Review Femasys Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
51.97%
↑ 51.97%
Operating Income Growth
-22.59%
↓ 22.59%
Net Income Growth
-32.07%
↓ 32.07%
Operating Cash Flow Growth
-72.37%
↓ 72.37%
Operating Margin
-1164.28%
↓ 1164.28%
Gross Margin
66.24%
↑ 66.24%
Net Profit Margin
-1242.56%
↓ 1242.56%
ROE
-392.43%
↓ 392.43%
ROIC
201.03%
↑ 201.03%
Femasys Inc. (FEMY) Income Statement & Financial Overview
Review Femasys Inc.'s (FEMY) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $581576.00 | $554908.00 | $221484.00 | $271140.00 |
| Cost of Revenue | $192407.00 | $190839.00 | $73125.00 | $312424.00 |
| Gross Profit | $389169.00 | $364069.00 | $148359.00 | -$41284.00 |
| Gross Profit Ratio | $0.67 | $0.66 | $0.67 | -$0.15 |
| R&D Expenses | $2.17M | $2.30M | $1.98M | $1.77M |
| SG&A Expenses | $2.86M | $3.10M | $2.59M | $1.65M |
| Operating Expenses | $5.11M | $5.48M | $4.63M | $3.42M |
| Total Costs & Expenses | $5.30M | $5.67M | $4.70M | $3.73M |
| Interest Income | $49504.00 | $124028.00 | $184138.00 | $224684.00 |
| Interest Expense | $440422.00 | $413290.00 | $388311.00 | $361552.00 |
| Depreciation & Amortization | $218255.00 | $215718.00 | $214135.00 | $223892.00 |
| EBITDA | -$4.45M | -$4.78M | -$4.08M | -$3.01M |
| EBITDA Ratio | -$7.66 | -$8.61 | -$18.44 | -$11.12 |
| Operating Income | -$4.72M | -$5.12M | -$4.48M | -$3.46M |
| Operating Income Ratio | -$8.12 | -$9.22 | -$20.24 | -$12.77 |
| Other Income/Expenses (Net) | -$390918.00 | -$289262.00 | -$204173.00 | -$136868.00 |
| Income Before Tax | -$5.11M | -$5.41M | -$4.69M | -$3.60M |
| Income Before Tax Ratio | -$8.79 | -$9.75 | -$21.16 | -$13.28 |
| Income Tax Expense | $10194.00 | $1158.00 | -$1750.00 | -$2.00 |
| Net Income | -$5.12M | -$5.41M | -$4.68M | -$3.60M |
| Net Income Ratio | -$8.81 | -$9.75 | -$21.15 | -$13.28 |
| EPS | -$0.23 | -$0.24 | -$0.21 | -$0.17 |
| Diluted EPS | -$0.23 | -$0.24 | -$0.21 | -$0.17 |
| Weighted Avg Shares Outstanding | $22.80M | $22.23M | $22.22M | $21.78M |
| Weighted Avg Shares Outstanding (Diluted) | $22.80M | $22.23M | $22.22M | $21.78M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan